Animal Models of Gastrointestinal Problems in Parkinson's Disease

被引:11
|
作者
Greene, James G. [1 ]
机构
[1] Emory Univ, Dept Neurol, Atlanta, GA 30322 USA
关键词
Parkinson's; gastrointestinal; enteric; constipation; gut; gastric emptying; animal models; MPTP; rotenone; synuclein; NIGROSTRIATAL DOPAMINE SYSTEM; ENTERIC NERVOUS-SYSTEM; LEWY-BODY-DISEASE; ALPHA-SYNUCLEIN AGGREGATION; BRAIN-STEM; TRANSGENIC MICE; BASAL GANGLIA; RESPONSE FLUCTUATIONS; CONTAINING NEURONS; PREFRONTAL CORTEX;
D O I
10.3233/JPD-2011-11033
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Gastrointestinal (GI) symptoms are being increasingly recognized as early, common, and severe features of Parkinson's disease (PD), and they are important determinants of quality of life and disability throughout the disease course. In addition, the concept that GI symptoms could represent "pre-motor" PD has been hotly debated and has recently become a driving force for investigations into the pathophysiology and neuropathology of PD. Clinical data has been supported by many pathological studies demonstrating alpha-synuclein neuritic pathology and neuronal loss in central and peripheral areas relevant to GI function. As understanding has matured concerning the impact of GI dysmotility on patients and its potential relationship to incipient PD, behavioral and neuropathological examination of the GI tract has become a critical aspect of evaluation and validation of PD animal models. This review will briefly summarize GI symptoms and neuropathology in PD important to model in animals, behavioral and neuropathological examination of the GI tract in animals, and the current state of modeling parkinsonian GI dysfunction in animal model systems.
引用
收藏
页码:137 / 149
页数:13
相关论文
共 50 条
  • [41] Cardiovascular Autonomic Dysfunction in Animal Models of Parkinson's Disease
    Fleming, Sheila M.
    [J]. JOURNAL OF PARKINSONS DISEASE, 2011, 1 (04) : 321 - 327
  • [42] Neuroprotection by immunomodulatory agents in animal models of Parkinson's disease
    Bridget Martinez
    Philip V.Peplow
    [J]. Neural Regeneration Research, 2018, 13 (09) : 1493 - 1506
  • [43] Evaluation of animal models of Parkinson's disease for neuroprotective strategies
    Emborg, ME
    [J]. JOURNAL OF NEUROSCIENCE METHODS, 2004, 139 (02) : 121 - 143
  • [44] Neuroprotective Effects of Temsirolimus in Animal Models of Parkinson’s Disease
    Rosalba Siracusa
    Irene Paterniti
    Marika Cordaro
    Rosalia Crupi
    Giuseppe Bruschetta
    Michela Campolo
    Salvatore Cuzzocrea
    Emanuela Esposito
    [J]. Molecular Neurobiology, 2018, 55 : 2403 - 2419
  • [45] Estrogen and SERM neuroprotection in animal models of Parkinson's disease
    Morissette, Marc
    Al Sweidi, Sara
    Callier, Sophie
    Di Paolo, Therese
    [J]. MOLECULAR AND CELLULAR ENDOCRINOLOGY, 2008, 290 (1-2) : 60 - 69
  • [46] Evaluation of motor disorders in animal models of Parkinson's disease
    Campos-Romo, A.
    [J]. REVISTA DE NEUROLOGIA, 2008, 46 (03) : 167 - 174
  • [47] Parkinson's disease: animal models and dopaminergic cell vulnerability
    Blesa, Javier
    Przedborski, Serge
    [J]. FRONTIERS IN NEUROANATOMY, 2014, 8
  • [48] Neuroprotection by estrogen in animal models of ischemia and Parkinson's disease
    Merchenthaler, I
    Shughrue, PJ
    [J]. DRUG DEVELOPMENT RESEARCH, 2005, 66 (02) : 172 - 181
  • [49] Exploring the Peripheral Initiation of Parkinson's Disease in Animal Models
    Sorrentino, Zachary A.
    Giasson, Benoit I.
    [J]. NEURON, 2019, 103 (04) : 547 - 549
  • [50] Animal models in the study of Alzheimer's disease and Parkinson's disease: A historical perspective
    Banerjee, Rajashree
    Rai, Arushi
    Iyer, Shreyas M.
    Narwal, Sonia
    Tare, Meghana
    [J]. ANIMAL MODELS AND EXPERIMENTAL MEDICINE, 2022, 5 (01) : 27 - 37